Ion Channels and Transporters as Druggable Targets in Oncology
Opportunity types being sought:
A specialised R&D-focused pharmaceutical company seeks to engage with Academic Experts, Centres of Excellence and University Spin‑Outs in order to acquire unique and consistent target validation data related to ion channels or transporters in oncology.
Research Interests
Our Client is seeking to collaborate with partners having data proving robust efficacy in cancer cells and/or tumor-bearing mice in response to genetic or pharmacologic interventions against ion channels or transporters. There is no limitation on cancer types and modes of action.
Submissions will be deemed extremely favourable if:
- Potential predictive biomarkers are identified
- Data is unpublished
Stage of Development
Our client is particularly interested in basic and pre‑clinical research.
Submission Information
Submission of 200‑300 word Academic Profiles and/or descriptions and capabilities of Academic Experts, Centres of Excellence and Spin‑Out Companies are encouraged.
Opportunity for Collaboration
Our client is open to a range of collaboration opportunities, with the most appropriate outcome being decided on a case by case basis. Example outcomes include licensing assets, joint patent applications, and research collaborations.
Jurisdictions of Interest
Our client is open to opportunities worldwide, with particular interest in submissions from non‑US and non‑European based research institutes and universities.